Mitral annular calcifications and aortic plaques as predictors of increased cardiovascular mortality

G Kamenský1, L Lisy, E Polak

  • 1Department of Noninvasive Cardiovascular Diagnostic, Ruzinov General Hospital, Ruzinovská 6, 826 06, Bratislava, Slovak Republic.

Insights

The combined presence of aortic plaques and mitral annular calcifications (MAC) significantly increases the risk of stroke and cardiac death. Simultaneous detection of both conditions indicates a higher severity of coronary artery disease.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Echocardiography

Background:

  • Mitral annular calcifications (MAC) and aortic plaques are established predictors of cardiovascular events.
  • Previous research indicates their individual association with recurrent embolic events, coronary artery disease, and cardiac mortality.
  • However, the combined impact of both aortic plaques and MAC on embolic events and cardiac deaths remains understudied.

Purpose of the Study:

  • To investigate the combined effect of aortic plaques and mitral annular calcifications (MAC) on the incidence of embolic events, stroke-related deaths, and total cardiac deaths.
  • To compare the predictive value of the simultaneous presence of both aortic plaques and MAC against their individual presence.

Main Methods:

  • A cohort of 100 patients with aortic plaques and 49 age- and sex-matched controls without aortic plaques were studied.
  • Transesophageal echocardiography was used to detect aortic plaques.
  • The incidence of embolic events, deaths associated with embolic events, and total cardiac deaths were evaluated during a mean follow-up of 32 months.
  • The effect of MAC presence or absence was also assessed.

Main Results:

  • Patients with aortic plaques exhibited higher rates of hypertension, hypercholesterolemia, smoking, MAC, and carotid artery atherosclerosis compared to controls.
  • Aortic plaque presence was associated with increased incidence of stroke/transient ischemic attack, stroke-related deaths, and total cardiac deaths.
  • Patients with both aortic plaques and MAC demonstrated a significantly higher incidence of stroke-related deaths (16.0 times higher) and total cardiac deaths (4.7 times higher) compared to those without both conditions.
  • Multivariate analysis identified MAC and hypercholesterolemia as independent predictors of stroke, and MAC and age for total cardiac death and stroke.

Conclusions:

  • The co-occurrence of aortic plaques and mitral annular calcifications (MAC) is a potent predictor of strokes, cerebral embolism deaths, and total cardiac deaths.
  • Simultaneous presence of both aortic plaque and MAC signifies a higher severity of coronary artery disease.
  • Combined findings are more predictive of adverse outcomes than either condition alone.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.